Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.

Address: Department of Internal Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA. Electronic address: [email protected].; Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute, Los Angeles, California, USA.; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.; Department of Nephrology and Renal Transplantation, CIC INSERM 1402, Centre Hospitalier Universitaire, University Hospital Poitiers, Poitiers, France.; Division of Nephrology, Mass General Brigham-Salem Hospital, Salem, Massachusetts, USA.; Division of Nephrology, Department of Medicine, University of Hong Kong, Hong Kong, China.; Renal and Transplant Centre, Imperial College London, London, UK.; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.; University of North Carolina Kidney Center at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Medicine, Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.; Division of Experimental Medicine & Immunotherapeutics, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; The George Institute for Global Health, New Delhi, India; School of Public Health, Imperial College London, London, UK; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.; The Kidney and Transplant Practice, Mount Elizabeth Novena Hospital, Singapore.; Nanjing University School of Medicine, Nanjing, China.; Department of Nephrology and Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion, Salvador Zubiran, Mexico City, Mexico.; Molecular Otolaryngology & Renal Research Laboratories, University of Iowa, Iowa City, Iowa, USA.; Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.; Ohio Kidney Associates, Columbus, Ohio, USA.; Divsion of Nephrology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Sorbonne University, and Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S1155, Paris, France; Le Mans Hospital, Le Mans, France.; Division of Nephrology, Department of Internal Medicine, University of Groningen, Groningen, The Netherlands.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Nephrology, Juntendo University, Tokyo, Japan.; Department of Nephrology, 1st Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic.; Department of Pediatric Subspecialties, Division of Nephrology and Dialysis, Ospedale Pediatrico Bambino Gesù, Rome, Italy.; Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.; MAGIC Evidence Ecosystem Foundation, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.; College of Medicine and Public Health, Flinders University, Adelaide, Australia; Cochrane Kidney and Transplant, Sydney, New South Wales, Australia.; Cochrane Kidney and Transplant, Sydney, New South Wales, Australia; Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; KDIGO, Brussels, Belgium.; Division of Nephrology, University Hospital, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Aachen, Germany. Electronic address: [email protected].